DE602005016680D1 - Verwendung von alkylfuranen zur herstellung eines antidiabetikums - Google Patents

Verwendung von alkylfuranen zur herstellung eines antidiabetikums

Info

Publication number
DE602005016680D1
DE602005016680D1 DE602005016680T DE602005016680T DE602005016680D1 DE 602005016680 D1 DE602005016680 D1 DE 602005016680D1 DE 602005016680 T DE602005016680 T DE 602005016680T DE 602005016680 T DE602005016680 T DE 602005016680T DE 602005016680 D1 DE602005016680 D1 DE 602005016680D1
Authority
DE
Germany
Prior art keywords
antidiability
alkylfuranes
manufacture
preventing
treating diabetes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005016680T
Other languages
English (en)
Inventor
Antoine Piccirilli
Philippe Msika
Nathalie Piccardi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Expanscience SA
Original Assignee
Laboratoires Expanscience SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Expanscience SA filed Critical Laboratoires Expanscience SA
Publication of DE602005016680D1 publication Critical patent/DE602005016680D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Furan Compounds (AREA)
DE602005016680T 2004-05-28 2005-05-27 Verwendung von alkylfuranen zur herstellung eines antidiabetikums Active DE602005016680D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0405782A FR2870742B1 (fr) 2004-05-28 2004-05-28 Utilisation d'alkyle furannes pour la preparation d'un medicament destine au traitement du diabete, de l'obesite et pour le traitement cosmetique de la cellulite et de la surcharge ponderale
PCT/FR2005/001310 WO2005117856A1 (fr) 2004-05-28 2005-05-27 Utilisation d’alkyle furannes pour la preparation d’un medicament destine au traitement du diabete

Publications (1)

Publication Number Publication Date
DE602005016680D1 true DE602005016680D1 (de) 2009-10-29

Family

ID=34946318

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005016680T Active DE602005016680D1 (de) 2004-05-28 2005-05-27 Verwendung von alkylfuranen zur herstellung eines antidiabetikums

Country Status (12)

Country Link
US (1) US8859617B2 (de)
EP (1) EP1765323B1 (de)
JP (1) JP4795337B2 (de)
CN (3) CN1972661B (de)
AT (1) ATE442845T1 (de)
CA (1) CA2566970C (de)
DE (1) DE602005016680D1 (de)
ES (2) ES2331847T3 (de)
FR (1) FR2870742B1 (de)
HK (1) HK1100167A1 (de)
MX (1) MXPA06013883A (de)
WO (1) WO2005117856A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2889956B1 (fr) * 2005-08-30 2012-04-20 Expanscience Lab Utilisation d'au moins un 2-alkyle furane, a titre de principe actif depigmentant ou eclaircissant
US9072717B2 (en) * 2007-09-18 2015-07-07 Elc Management Llc Cosmetic compositions containing alpha glucosidase inhibitors and methods of use
US20100135945A1 (en) * 2008-12-02 2010-06-03 Kreations By Kristin, Llc Gymnema-containing lip balm compositions and associated methods
FR2949044B1 (fr) * 2009-08-12 2021-05-07 Expanscience Lab Composition comprenant une fraction d'insaponifiable
JP5818300B2 (ja) * 2010-12-27 2015-11-18 雪印メグミルク株式会社 ミルクセラミド含有食品及びその製造方法
FR2985665B1 (fr) * 2012-01-13 2015-10-02 Expanscience Lab Utilisation de peau d'avocat pour obtenir un insaponifiable d'avocat enrichi en hydrocarbures aliphatiques satures et en sterols
EP2978422A4 (de) * 2013-03-29 2017-04-05 Avoscience, LLC Lipidfuran-, pyrrol- und thiophenverbindungen zur behandlung von krebs, neurologischen erkrankungen und fibrotischen erkrankungen
US20170312246A1 (en) 2016-04-27 2017-11-02 Avoscience, Llc Lipidic furan, pyrrole, and thiophene compounds for use in the treatment of atrophic vaginitis

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4127592A (en) * 1977-03-31 1978-11-28 Polak's Frutal Works, B.V. Process of the preparation of hydroxyfurenones
IL63632A (en) * 1980-08-27 1986-02-28 Merrell Dow Pharma Acylated furanyl and thienyl acrylic acids and process for their preparation
EP0110548B1 (de) 1982-10-29 1987-06-24 Plessey Overseas Limited Elektrisch leitende Dichtungen
FR2678632B1 (fr) * 1991-07-03 1994-09-02 Pharmascience Lab Procede de preparation de l'insaponifiable d'avocat permettant d'ameliorer sa teneur en l'une de ses fractions dite h.
FR2678614A1 (fr) * 1991-07-03 1993-01-08 Pharmascience Lab Compose presentant une activite en tant qu'inhibiteur de la collagenase et medicament le contenant.
RU1838296C (ru) * 1991-11-27 1995-12-20 Всесоюзный научный центр по безопасности биологически активных веществ Производные арилсульфокислот, проявляющие гипогликемическую активность
US5468490A (en) * 1993-10-25 1995-11-21 Conkle & Olesten Lipidic furans useful for skin therapeutics
JPH08332061A (ja) 1995-06-07 1996-12-17 Sanki Shoji Kk アボカド葉茶とその飲料及び抽出液乾固物
JP2000514055A (ja) * 1996-07-02 2000-10-24 ジュウ，サング，スプ ２―ヒドロキシプロピオン酸誘導体及びその製造方法
JP4047441B2 (ja) 1998-03-05 2008-02-13 株式会社資生堂 脂質分解促進剤および痩身用皮膚外用剤
CA2334312A1 (en) * 1998-06-26 2000-01-06 Takara Shuzo Co., Ltd. Therapeutic agents
JP2000144170A (ja) * 1998-09-01 2000-05-26 Janifu Tekku:Kk 抗肥満及び内臓蓄積脂肪低減化機能を有する物質、及びその用途
DE19901502C1 (de) 1999-01-11 2000-09-21 Michael Schneider Anticellulitiszusammensetzung und ihre Verwendung
DE19908535A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Verwendung von polycyclischen Thiazol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
FR2798667B1 (fr) * 1999-09-22 2001-12-21 Pharmascience Lab Procede d'extraction des composes furaniques et alcools gras polyhydroxyles de l'avocat, composition a base de et utilisation de ces composes en therapeutique, cosmetique et alimentaire
JP4693964B2 (ja) * 2000-08-07 2011-06-01 カゴメ株式会社 新規摂食抑制剤
JP2002212177A (ja) * 2000-11-14 2002-07-31 Takeda Chem Ind Ltd 脂質代謝改善剤
CA2435067C (en) * 2001-01-26 2011-11-15 Chugai Seiyaku Kabushiki Kaisha Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
US20030120073A1 (en) * 2001-04-25 2003-06-26 Seto Christopher T. Alpha-ketocarboxylic acid based inhibitors of phosphoryl tyrosine phosphatases
JP2005232005A (ja) * 2001-07-02 2005-09-02 Maruha Corp 新規脂肪族化合物、合成方法、利用方法
WO2003007888A2 (en) * 2001-07-20 2003-01-30 Adipogenix, Inc. Fat accumulation-modulating compounds
WO2003048316A2 (en) * 2001-11-30 2003-06-12 Bristol-Myers Squibb Company Polynucleotides encoding novel human mitochondrial and microsomal glycerol-3-phosphate acyl-transferases and variants thereof
FR2841470B1 (fr) * 2002-06-27 2006-01-13 Pharmascience Lab Utilisation d'isoflavones pour la preparation de compositions topiques utiles pour favoriser l'amincissement et methode de traitement cosmetique associee
WO2004016106A1 (fr) 2002-07-29 2004-02-26 Laboratoires Expanscience Procede d'obtention d'un insaponifiable d'avocat riche en lipides furaniques
US6793946B2 (en) 2002-07-31 2004-09-21 Access Business Group International Llc. Composition and method for lowering cholesterol
FR2856294B1 (fr) 2003-06-18 2005-08-05 Expanscience Lab Utilisation cosmetique d'une composition comprenant au moins une oxazoline, a titre de principe actif, comme amincissant et/ou pour prevenir et/ou traiter la cellulite
US20050048144A1 (en) * 2003-08-29 2005-03-03 Xiao-Qing Han Herb extract-based cosmeceutical cream for controlling the blood sugar level of diabetes and methods for making it
DE602005020274D1 (de) * 2004-05-28 2010-05-12 Expanscience Lab Verwendung von furanalkylen zur herstellung eines arzneimittels für die behandlung von adipositas sowie kosmetische behandlung von übergewicht

Also Published As

Publication number Publication date
CN1972661A (zh) 2007-05-30
HK1100167A1 (en) 2007-09-07
CN1960722A (zh) 2007-05-09
CN1960723B (zh) 2010-09-08
CN1960723A (zh) 2007-05-09
ES2364153T3 (es) 2011-08-25
FR2870742A1 (fr) 2005-12-02
US8859617B2 (en) 2014-10-14
ES2331847T3 (es) 2010-01-18
CA2566970C (fr) 2012-08-28
EP1765323A1 (de) 2007-03-28
JP2008501003A (ja) 2008-01-17
EP1765323B1 (de) 2009-09-16
JP4795337B2 (ja) 2011-10-19
FR2870742B1 (fr) 2008-03-14
CN1972661B (zh) 2011-03-16
CA2566970A1 (fr) 2005-12-15
ATE442845T1 (de) 2009-10-15
CN1960722B (zh) 2010-09-08
WO2005117856A1 (fr) 2005-12-15
US20080081837A1 (en) 2008-04-03
MXPA06013883A (es) 2007-01-26

Similar Documents

Publication Publication Date Title
DE602005016680D1 (de) Verwendung von alkylfuranen zur herstellung eines antidiabetikums
CY1115180T1 (el) Επιλογες θεραπειας για τη νοσο του fabry
IL173203A0 (en) Novel cyano thiazolides, methods for the production thereof, and use thereof as a medicament
EA200000747A1 (ru) СПОСОБ ВВЕДЕНИЯ AspB28-ИНСУЛИНА ЧЕЛОВЕКА
ATE462427T1 (de) Verwendung von treprostinil zur behandlung von neuropathischen diabetischen fussgeschwüren
ATE448732T1 (de) Sammlung von informationen zur aktivität und schlafqualität mit einem medizinprodukt
DE60103453D1 (de) Verwendung von albuminstabilisiertem Paclitaxel zur Herstellung eines Arzneimittels zum Behandeln von festen Tumoren und das so erhaltene Arzneimittel
WO2009132656A3 (en) Crystal structure of human sortilin and uses thereof for identifying ligands to sortilin
ATE464895T1 (de) Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von depressionen
ATE420099T1 (de) Medikament zur wachstumsinhibierung von tumoren
ATE289816T1 (de) Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen
ATE421313T1 (de) Verwendung einer dihydrochalcon-reichen phenolischen fraktion für eine kosmetische behandlung
SE0102147D0 (sv) New methods
WO2005044334A3 (en) Colorful shielded reciprocating butterfly needle
DE602004010691D1 (de) Verwendung von xenon mit hypothermie zur behandlung von neugeborenen-asphyxie
ATE382362T1 (de) Verwendung und herstellung von saponinfreien spargelextrakten
ATE303819T1 (de) Verwendung von langem pentraxin ptx3 zur herstellung eines arzneimittels zur verhütung und heilung von autoimmunkrankheiten
ATE157354T1 (de) Verwendung von cucurbitine zur herstellung einer kosmetischen oder pharmazeutischen zusammensetzung zur dermatologischen, anti- allergischen anwendung
DK1596879T3 (da) Anvendelse af kahalalidforbindelser til fremstilling af et medikament til behandling af psoriasis
ATE408602T1 (de) Monohyroxycarbamezepin zur verwendung bei der herstellung eines medikaments zur behandlung von affektiver psychose, aufmerksamkeits störungen und neuropathischen schmerzen
DK1675611T3 (da) Terapeutiske anvendelser for C-peptid
ATE517631T1 (de) Prozess zur herstellung von ferutinin aus pflanzen der ferulafamilie
ATE239492T1 (de) Verwendung von einem bpi protein zur herstellung eines medikamentes zur behandlung von chronischen herzerkrankungen
DE60135911D1 (de) vERWENDUNG VON SULODEXIDE ZUR BEHANDLUNG VON DIABETISCHER NEPHROPATHIE
DE69720064D1 (de) Verwendung von comt inhibitoren zur herstellung eines arzneimittels zur vorbeugung von diabetischen vaskulären funktionsstörungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition